{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/degarelix.json","peptide":{"slug":"degarelix","name":"Degarelix","url":"https://peptidescanner.com/peptides/degarelix/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":63,"entries":[{"objectId":"story:pubmed-pmid-43041099-degarelix:v1","state":"current","stateChangedAt":"2026-11-17","title":"Development and Validation of a Stability-Indicating HPLC Method for Degarelix and Characterization of Its Degradation Impurities Using LC-MS, 1H NMR, and FTIR Techniques.","domain":"Literature metadata","dateInSource":"2026-11-17","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-43041099-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-43041099-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-43041099-degarelix-v1","contentSha256":"48e923b4bc4a076fc1942e60af3fa9a76df45b2d959a07672b38d2363e5aef92"},{"objectId":"story:clinicaltrials-gov-nct00116753-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00116753","domain":"Clinical trials","dateInSource":"2010-12-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00116753-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00116753-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00116753-degarelix-v1","contentSha256":"6443b15951141369a35b00a0576792b49ecaeb92894307cc9a2ce551575fdfb9"},{"objectId":"story:clinicaltrials-gov-nct00116779-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00116779","domain":"Clinical trials","dateInSource":"2011-12-19","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00116779-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00116779-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00116779-degarelix-v1","contentSha256":"a0da9e411a68f2b444bc60b8b9c8ad6c2c10d1a01ecd8d7a1eeba8294ea72b49"},{"objectId":"story:clinicaltrials-gov-nct00117286-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00117286","domain":"Clinical trials","dateInSource":"2025-12-18","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00117286-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00117286-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00117286-degarelix-v1","contentSha256":"3d12e56c65fe5e161f10b6fc0d7bb1b37963a7ff40ec8dc553c8126537ca8e38"},{"objectId":"story:clinicaltrials-gov-nct00117949-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00117949","domain":"Clinical trials","dateInSource":"2011-05-23","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00117949-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00117949-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00117949-degarelix-v1","contentSha256":"8984daced565c6551cdb983f391b9937761bf7fe85802c65155eee497f1007f9"},{"objectId":"story:clinicaltrials-gov-nct00215683-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00215683","domain":"Clinical trials","dateInSource":"2015-04-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00215683-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00215683-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00215683-degarelix-v1","contentSha256":"9d4d3568eafacf9be923d3e923a16417ce1b30e9064f41547d1139fbe8172381"},{"objectId":"story:clinicaltrials-gov-nct00268892-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00268892","domain":"Clinical trials","dateInSource":"2010-12-24","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00268892-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00268892-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00268892-degarelix-v1","contentSha256":"28ec37141daaf8870f061046b715a51f932077a6a0d23df1012aabc7f023996c"},{"objectId":"story:clinicaltrials-gov-nct00295750-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00295750","domain":"Clinical trials","dateInSource":"2012-12-19","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00295750-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00295750-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00295750-degarelix-v1","contentSha256":"517961d7deee86581012876a9323e95487ef44953a4a0aa601e818ff9aaeae8d"},{"objectId":"story:clinicaltrials-gov-nct00451958-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00451958","domain":"Clinical trials","dateInSource":"2013-03-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00451958-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00451958-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00451958-degarelix-v1","contentSha256":"1a976d63377d28db5cf5b5436d4710403834515d72847f11828dbb1d3c08f38a"},{"objectId":"story:clinicaltrials-gov-nct00468286-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00468286","domain":"Clinical trials","dateInSource":"2011-03-23","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00468286-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00468286-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00468286-degarelix-v1","contentSha256":"57d3e8c66373d6bc41309de072b79e3761ddd891edc8833b3c200c31850ab76b"},{"objectId":"story:clinicaltrials-gov-nct00527488-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00527488","domain":"Clinical trials","dateInSource":"2015-05-04","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00527488-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00527488-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00527488-degarelix-v1","contentSha256":"41307242886464c1ecc2ca434f5b4b2bb5df77bfe84a5fc029be54ce47ad438d"},{"objectId":"story:clinicaltrials-gov-nct00738673-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00738673","domain":"Clinical trials","dateInSource":"2013-01-18","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00738673-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00738673-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00738673-degarelix-v1","contentSha256":"8c70df9fa4950201f322043f7603a30103c5b975009c93f5f828be7dc413be85"},{"objectId":"story:clinicaltrials-gov-nct00801242-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00801242","domain":"Clinical trials","dateInSource":"2014-09-03","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00801242-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00801242-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00801242-degarelix-v1","contentSha256":"4140d3ea920571e315ae1829172397aeae6cbfd4959c2d191cdd4af257568510"},{"objectId":"story:clinicaltrials-gov-nct00818623-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00818623","domain":"Clinical trials","dateInSource":"2023-11-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00818623-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00818623-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00818623-degarelix-v1","contentSha256":"f4c96faf5b3ffd3e90edaf24da69c7a63e4602219f6f2e659420a40d711957fd"},{"objectId":"story:clinicaltrials-gov-nct00819156-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00819156","domain":"Clinical trials","dateInSource":"2023-11-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00819156-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00819156-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00819156-degarelix-v1","contentSha256":"c54b9dcba63011e2a79c62ace8b4686e501f7b9d542cc87f368b612ed2be1dad"},{"objectId":"story:clinicaltrials-gov-nct00819247-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00819247","domain":"Clinical trials","dateInSource":"2023-11-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00819247-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00819247-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00819247-degarelix-v1","contentSha256":"f6d473a31dc71557437d9aa6927c4735cc53757915392f4c2ff3973a071ef39a"},{"objectId":"story:clinicaltrials-gov-nct00947882-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00947882","domain":"Clinical trials","dateInSource":"2015-06-08","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00947882-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00947882-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00947882-degarelix-v1","contentSha256":"9bdc0b58fce452149294db28306c29b47754e0bed947ba879d8c09c2e046b3c0"},{"objectId":"story:clinicaltrials-gov-nct00967018-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00967018","domain":"Clinical trials","dateInSource":"2013-01-03","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00967018-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00967018-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00967018-degarelix-v1","contentSha256":"418365debe1c4dd3ac520ea3170be0bc7385f529d89df5c53af17bdfa2bb2dc5"},{"objectId":"story:clinicaltrials-gov-nct01071915-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01071915","domain":"Clinical trials","dateInSource":"2013-02-12","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01071915-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01071915-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct01071915-degarelix-v1","contentSha256":"2d022fc34c7160eb58f0ad3ed6546486753b9a95f28f7781acae79b75b7df393"},{"objectId":"story:clinicaltrials-gov-nct01215513-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01215513","domain":"Clinical trials","dateInSource":"2013-05-22","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01215513-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01215513-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct01215513-degarelix-v1","contentSha256":"663592b5eac8ac16c9cdcd6b89a68d8863c2f55d7180f53324bc4435cc56f251"},{"objectId":"story:clinicaltrials-gov-nct01220869-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01220869","domain":"Clinical trials","dateInSource":"2025-04-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01220869-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01220869-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct01220869-degarelix-v1","contentSha256":"14a0f73f5455bf632bca5cb5c9f7cfb4ce6c220e9f62144b52822e689409792f"},{"objectId":"story:clinicaltrials-gov-nct01696877-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01696877","domain":"Clinical trials","dateInSource":"2019-03-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01696877-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01696877-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct01696877-degarelix-v1","contentSha256":"80d3c6aa36fce0b8b2b7b29b2a1d287ef91a57d3b083e276dcfe8f880e6926b6"},{"objectId":"story:clinicaltrials-gov-nct01731912-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01731912","domain":"Clinical trials","dateInSource":"2019-01-18","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01731912-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01731912-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct01731912-degarelix-v1","contentSha256":"b6a9095a6098581e83ede9e7ce20ea0072e3fe86f0b0ba1257e785be9ec74069"},{"objectId":"story:clinicaltrials-gov-nct01751451-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01751451","domain":"Clinical trials","dateInSource":"2021-11-19","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01751451-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01751451-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct01751451-degarelix-v1","contentSha256":"dfc099c4b04b3141fb1a2dcd7d224ac83d1aca323a27237d79b5b6f6d6217c3b"},{"objectId":"story:clinicaltrials-gov-nct02135445-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02135445","domain":"Clinical trials","dateInSource":"2017-04-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02135445-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct02135445-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct02135445-degarelix-v1","contentSha256":"d907761e33758a7ac579f97147c6ae17a67d43baf9d77cc1cd0effbb0faf716a"},{"objectId":"story:clinicaltrials-gov-nct02489357-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02489357","domain":"Clinical trials","dateInSource":"2021-11-12","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02489357-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct02489357-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct02489357-degarelix-v1","contentSha256":"17d32b23e66dfae26beccebba8e9bad215443a8b01cc519d278dd1098bda31ed"},{"objectId":"story:clinicaltrials-gov-nct02849990-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02849990","domain":"Clinical trials","dateInSource":"2022-01-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02849990-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct02849990-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct02849990-degarelix-v1","contentSha256":"94db65506bdc50b6fade69ed5a6c877f05de01739d599f4951838d3dfc6ae284"},{"objectId":"story:clinicaltrials-gov-nct03069937-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03069937","domain":"Clinical trials","dateInSource":"2025-10-15","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03069937-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct03069937-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct03069937-degarelix-v1","contentSha256":"31b87a4d23499c4e05924776d7258d7a570a0d647c3a6cfb1f32df51c24e4771"},{"objectId":"story:clinicaltrials-gov-nct03689699-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03689699","domain":"Clinical trials","dateInSource":"2026-10-15","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03689699-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct03689699-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct03689699-degarelix-v1","contentSha256":"827bbdd0826aa50a5ba5d4b19394f0f9aee4e53b12f345980d52c6530b157f44"},{"objectId":"story:clinicaltrials-gov-nct04397718-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT04397718","domain":"Clinical trials","dateInSource":"2022-06-06","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04397718-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct04397718-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct04397718-degarelix-v1","contentSha256":"94294fa4a655c3788474b96b0ef7c7e6325a9b91a13de5da952b0bbfcbfb3746"},{"objectId":"story:clinicaltrials-gov-nct05181800-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT05181800","domain":"Clinical trials","dateInSource":"2024-09-27","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05181800-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct05181800-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct05181800-degarelix-v1","contentSha256":"e6faade9ea24a4fbb9bbeae54c0df08a1d738265b1166e51ba535caeb4cf4bdb"},{"objectId":"story:fda-drugs-nda022201:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application NDA022201","domain":"Regulatory","dateInSource":"2008-12-24","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda022201/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#fda-drugs-nda022201-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#fda-drugs-nda022201-v1","contentSha256":"a159727ce7f20025e1afe8d2c6611b79d8e5d77d1378c64a5460ded48073a9e1"},{"objectId":"story:federal-register-2010-4159:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice 2010-4159","domain":"Regulatory","dateInSource":"2010-03-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-2010-4159/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#federal-register-2010-4159-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#federal-register-2010-4159-v1","contentSha256":"de1bf813ff0f7c773fc6bcddb7419e505983909a84dffc97ef0a442bb42fe928"},{"objectId":"story:pubmed-pmid-19453267-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Degarelix for prostate cancer.","domain":"Literature metadata","dateInSource":"2009-05-26","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-19453267-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-19453267-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-19453267-degarelix-v1","contentSha256":"14d814b9ab79bbc56a661415ce1d36d0dbf7020664c7ff58ca93b0a8023eed9c"},{"objectId":"story:pubmed-pmid-19838145-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Degarelix (firmagon) for prostate cancer.","domain":"Literature metadata","dateInSource":"2013-11-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-19838145-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-19838145-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-19838145-degarelix-v1","contentSha256":"abcb72e2966ae0e91551264d277ffd24bfd4148a15d3325cd538963eb6cfce99"},{"objectId":"story:pubmed-pmid-20069136-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Degarelix acetate for the treatment of prostate cancer.","domain":"Literature metadata","dateInSource":"2025-08-04","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20069136-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-20069136-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-20069136-degarelix-v1","contentSha256":"9412422e7530d3bf6f8b7194ad6d295d7179a03ce0e30477ff22765925db069a"},{"objectId":"story:pubmed-pmid-21188095-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Evaluation of degarelix in the management of prostate cancer.","domain":"Literature metadata","dateInSource":"2024-04-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-21188095-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-21188095-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-21188095-degarelix-v1","contentSha256":"71ffb27070d7b8061cafbd32ec38f81d28fc62ce617518fbd9887e3e544e6406"},{"objectId":"story:pubmed-pmid-21496210-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"In vitro studies investigating the interactions between degarelix, a decapeptide gonadotropin-releasing hormone blocker, and cytochrome P450.","domain":"Literature metadata","dateInSource":"2014-11-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-21496210-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-21496210-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-21496210-degarelix-v1","contentSha256":"bd51c7c405a2606a3b112a1a2e01a18cf02e8627a83a236b30b44541547d116a"},{"objectId":"story:pubmed-pmid-21768273-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Metabolite profiles of degarelix, a new gonadotropin-releasing hormone receptor antagonist, in rat, dog, and monkey.","domain":"Literature metadata","dateInSource":"2025-02-12","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-21768273-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-21768273-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-21768273-degarelix-v1","contentSha256":"da8446efbf1f20877c8b06ae280b1cf9ad70be9eeb763cd6769cb844afbd6c32"},{"objectId":"story:pubmed-pmid-22082230-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Degarelix: an antagonist to GnRH--theoretical and treatment considerations in paraphilia.","domain":"Literature metadata","dateInSource":"2015-11-19","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-22082230-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-22082230-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-22082230-degarelix-v1","contentSha256":"ad43e762afe07f55b3e74be61707bd2bd760dbde4ab13c3aec8ce756cf66379f"},{"objectId":"story:pubmed-pmid-23431078-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Degarelix as a new antiangiogenic agent for metastatic colon cancer?","domain":"Literature metadata","dateInSource":"2021-10-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23431078-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-23431078-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-23431078-degarelix-v1","contentSha256":"9b23713036a883f481ff5cade20f64d024794b8f403896b9719fa22d9f01b0ac"},{"objectId":"story:pubmed-pmid-23589543-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"In vitro and in vivo human metabolism of degarelix, a gonadotropin-releasing hormone receptor blocker.","domain":"Literature metadata","dateInSource":"2025-02-12","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23589543-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-23589543-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-23589543-degarelix-v1","contentSha256":"a871580e8dbf6b72c0f19c386121424ee379e9aa24771129ab702d50dfb1623a"},{"objectId":"story:pubmed-pmid-23783053-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Management of a patient with locally advanced prostate cancer with degarelix: a case report.","domain":"Literature metadata","dateInSource":"2013-06-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23783053-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-23783053-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-23783053-degarelix-v1","contentSha256":"ef2710f128d4f5e6c84508d5fc61051d21bef1a8f192bc966a8274596d40f599"},{"objectId":"story:pubmed-pmid-24473414-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Tipping the balance in favour of degarelix for ADT.","domain":"Literature metadata","dateInSource":"2021-10-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-24473414-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-24473414-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-24473414-degarelix-v1","contentSha256":"43f29eb0032a49fe0b461b27d778ff7f41732e9f77a1d10185b41cb6c8fdb212"},{"objectId":"story:pubmed-pmid-24568188-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"A cost-utility analysis of degarelix in the treatment of advanced hormone-dependent prostate cancer in the United Kingdom.","domain":"Literature metadata","dateInSource":"2026-01-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-24568188-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-24568188-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-24568188-degarelix-v1","contentSha256":"d00478db81ed88a02d5b4b24fd8877dfc8cc7244893eabc394ce328ab4c23a20"},{"objectId":"story:pubmed-pmid-25851250-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Gonadotropin-releasing hormone receptor-targeted paclitaxel-degarelix conjugate: synthesis and in vitro evaluation.","domain":"Literature metadata","dateInSource":"2015-06-23","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-25851250-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-25851250-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-25851250-degarelix-v1","contentSha256":"2cb3a6379f6fe4e1d5c3c0538b03a3e36bb67d9d819b575368e5bb5a41f43ecb"},{"objectId":"story:pubmed-pmid-27756786-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy.","domain":"Literature metadata","dateInSource":"2017-11-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-27756786-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-27756786-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-27756786-degarelix-v1","contentSha256":"070acaeaf167f6ead61df4ee77b030ed263654b2b97b2937b8609155daa4b760"},{"objectId":"story:pubmed-pmid-28480768-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Degarelix versus luteinizing hormone-releasing hormone agonists for the treatment of prostate cancer.","domain":"Literature metadata","dateInSource":"2024-07-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-28480768-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-28480768-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-28480768-degarelix-v1","contentSha256":"1a54ed617b3c40b7896ec7423a89b0b2a6875f4dfea685e3d7ef35fa36bfc156"},{"objectId":"story:pubmed-pmid-28753747-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy.","domain":"Literature metadata","dateInSource":"2018-12-17","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-28753747-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-28753747-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-28753747-degarelix-v1","contentSha256":"b6aee97304d142281a65e095cfa0ba21df13e8ecc06f2065c5b3f5ab170110b8"},{"objectId":"story:pubmed-pmid-28960413-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"An efficient synthesis of deuterium-labeled degarelix acetate, a third-generation gonadotropin-releasing hormone receptor antagonist.","domain":"Literature metadata","dateInSource":"2019-09-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-28960413-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-28960413-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-28960413-degarelix-v1","contentSha256":"5fd610f5563210469680b8e7cf3f21967e380e1f9a816db34099c6aff2753d20"},{"objectId":"story:pubmed-pmid-29264358-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer.","domain":"Literature metadata","dateInSource":"2022-03-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29264358-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-29264358-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-29264358-degarelix-v1","contentSha256":"30b182735c41002d2bd54a25db2fc9ef0afd3160094f3a6b1e120de10be407b0"},{"objectId":"story:pubmed-pmid-29534997-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermitten…","domain":"Literature metadata","dateInSource":"2021-11-22","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29534997-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-29534997-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-29534997-degarelix-v1","contentSha256":"708cd6d3b026dc042f4c64bd7f7a326e1ae62a58f246a7883668b25564189def"},{"objectId":"story:pubmed-pmid-32573666-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Prostate Cancer Drug Degarelix Rapidly Treats Pedophilic Disorder.","domain":"Literature metadata","dateInSource":"2020-06-26","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-32573666-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-32573666-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-32573666-degarelix-v1","contentSha256":"3ad95889db836c1906bbf128aaf2f816aff0286ec7ce9900a5afef1d9e738f6c"},{"objectId":"story:pubmed-pmid-33586081-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"A Real-Time NMR Method for Measurement of In Vitro Aggregation Kinetics Of Degarelix Drug Products.","domain":"Literature metadata","dateInSource":"2021-03-24","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-33586081-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-33586081-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-33586081-degarelix-v1","contentSha256":"795994ffa4459d44c8e11e49a164928dff4f63eed6a11d99e281daf923a18fe8"},{"objectId":"story:pubmed-pmid-34350976-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Degarelix for treating advanced hormone-sensitive prostate cancer.","domain":"Literature metadata","dateInSource":"2025-06-23","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-34350976-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-34350976-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-34350976-degarelix-v1","contentSha256":"66b3ce348c82c45aa22f3c1c4ef8868d9d0650238e56bb1b25d302e1d1854d52"},{"objectId":"story:pubmed-pmid-34907463-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"[Treatment of advanced hormone-sensitive prostate cancer using degarelix].","domain":"Literature metadata","dateInSource":"2026-10-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-34907463-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-34907463-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-34907463-degarelix-v1","contentSha256":"12317cb77a3301913b1903a591143e6380db9a607a10eed3c862abbf947eb848"},{"objectId":"story:pubmed-pmid-34934969-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy.","domain":"Literature metadata","dateInSource":"2022-07-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-34934969-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-34934969-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-34934969-degarelix-v1","contentSha256":"32acd72e0c5ea3ddfb717f77b8ba27a735e6a41e64c5a7e0c84e7f6c796c2864"},{"objectId":"story:pubmed-pmid-35069083-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Patients and physician satisfaction of Degarelix in androgen deprivation therapy for advanced hormone-dependent prostate cancer in the Netherlands.","domain":"Literature metadata","dateInSource":"2022-04-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-35069083-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-35069083-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-35069083-degarelix-v1","contentSha256":"b324b96f75a5d6e7f33fdc3678d29b02851d63023c5d395b6d997edbd7bd4048"},{"objectId":"story:pubmed-pmid-35923949-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Degarelix vs. leuprorelin for the treatment of prostate cancer in China: A cost-utility analysis.","domain":"Literature metadata","dateInSource":"2025-10-31","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-35923949-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-35923949-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-35923949-degarelix-v1","contentSha256":"c43d63c1326d4d9fbd52828ec98317d42b2ea7e2bb77eec77953ba2debcda9e2"},{"objectId":"story:pubmed-pmid-37455491-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Investigation of the GnRH antagonist degarelix isomerization in biological matrices.","domain":"Literature metadata","dateInSource":"2023-07-19","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37455491-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-37455491-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-37455491-degarelix-v1","contentSha256":"4b1ac3a4b72ed19e519c5f9a088b3549048fd2d706c69a534f775269399110b7"},{"objectId":"story:pubmed-pmid-38413843-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix.","domain":"Literature metadata","dateInSource":"2026-07-24","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38413843-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-38413843-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-38413843-degarelix-v1","contentSha256":"b6b9014cb881647b09a66fd9e6eb8f5c6b966d01d1eacb87169b510e796c964d"},{"objectId":"story:pubmed-pmid-41918172-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Resting state functional connectivity in paedophilic disorder and degarelix treatment.","domain":"Literature metadata","dateInSource":"2026-08-14","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41918172-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-41918172-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-41918172-degarelix-v1","contentSha256":"fb1269bdea47a7fd8a1db088f9a5ebca72f0e5d001e0b9cbbbd5b28d35ff45e5"},{"objectId":"story:pubmed-pmid-41970125-degarelix:v1","state":"current","stateChangedAt":"2026-11-15","title":"Fatal Interstitial Pneumonitis During Combined Degarelix, Darolutamide, and Docetaxel Therapy for Metastatic Prostate Cancer.","domain":"Literature metadata","dateInSource":"2026-08-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41970125-degarelix/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-41970125-degarelix-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-41970125-degarelix-v1","contentSha256":"a5839deab4fc7bab75891cc4686e156cb89e4ed4923bb0ccfa66b437632c9acf"}]}
